ADVFN - Advanced Financial Network.
HOME» NYSE » A » ABT Stock Price » ABT Stock News

Abbott Labs Share News

 Abbott Laboratories Stock Price
ABT Stock Price
 Abbott Laboratories Stock Chart
ABT Stock Chart
 Abbott Laboratories Stock News
ABT Stock News
 Abbott Laboratories Company Information
ABT Company Information
 Abbott Laboratories Stock Trades
ABT Stock Trades

Abbott Laboratories Executive: Planning to Grow Nutrition Business in India

By Rumman Ahmed BANGALORE--Abbott Laboratories (ABT) is looking at having a fully integrated business model to grow its nutrition business in India, where it has plans to add local manufacturing as well as sales and distribution functions to its research and development capabilities, a senior executive said Monday. Abbott Monday inaugurated its first nutrition research and development center in the South Asian nation through a tie-up with a unit of Indian biotechnology company Biocon Ltd. (532523.BY). "India is a growth area for us. We have research now. To be fully integrated, we will have everything from research to manufacturing to sales (in India)," John Landgraf, executive vice president of Abbott's global nutrition business, said in an interview. Mr. Landgraf didn't elaborate on Abbott's plans for setting up local manufacturing operations, but said it is the "next phase" of the company's programs for the nutrition business in India. Abbott had last month unveiled its collaboration with Syngene International Ltd., Biocon's contract research unit, to develop nutrition products targeting those afflicted by malnutrition and diabetes in the South Asian nation. Write to Rumman Ahmed in Bangalore at rumman.ahmed@dowjones.com

Stock News for Abbott Labs (ABT)
DateTimeHeadline
12/07/201614:01:00Abbott Seeks to Terminate Alere Deal -- Update
12/07/201613:30:00Abbott Seeks to Terminate Alere Deal
12/07/201612:59:00Alere Issues Statement Regarding Abbott Lawsuit
12/07/201612:54:00Abbott Seeks to Terminate Alere Deal
12/07/201611:14:00Abbott Seeks to Terminate Alere Acquisition
12/06/201608:00:00Study: Hospital Nutrition Program Shortens Patient Stays and...
11/30/201607:00:00Abbott Announces CE Mark for i-STAT Alinity, a Pioneering, Handheld...
11/23/201609:01:43Current Report Filing (8-k)
11/21/201606:02:19Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)
11/18/201617:03:53Statement of Changes in Beneficial Ownership (4)
11/18/201606:02:59Free Writing Prospectus - Filing Under Securities Act Rules 163/433...
11/17/201609:15:00Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)
11/17/201609:07:46Current Report Filing (8-k)
11/17/201608:45:00Biotech Stocks Forge Ahead With Confidence on This Week's Healthy...
11/17/201602:00:50Aqua Bio Technology: Increased income and EBITDA in 3rd quarter...
11/16/201617:22:00Current Report Filing (8-k)
11/14/201610:05:48Statement of Changes in Beneficial Ownership (4)
11/14/201610:05:22Statement of Changes in Beneficial Ownership (4)
11/14/201610:04:29Statement of Changes in Beneficial Ownership (4)
11/14/201610:04:04Statement of Changes in Beneficial Ownership (4)

Abbott Laboratories and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2016 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US